Maravai Lifesciences Holdings, Inc. (MRVI)
Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: United States
Exchange: NASDAQ
Market cap: $1.81B
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Latest financial period: June 30, 2026
Filed with the SEC: August 7, 2026
Estimated earnings date: November 5, 2026
Profit #1468 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | -46.7% | -50.2% | -57.4% | -46.9% |
Growth #1388 of 1484 companies
Payout #1117 of 1484 companies
Safety #1362 of 1484 companies
Price #1392 of 1484 companies
